(Medical Xpress)—Oxford University scientists have discovered a compound that greatly boosts the effect of vaccines against viruses like flu, HIV and herpes in mice.
Biotechnology
Aug 26, 2012
0
0
The discovery of the molecule, an antibody known as CR6261, is good news for researchers who hope to design a flu vaccine that would give humans lifelong protection against a majority of influenza viruses. The antibody also ...
Biochemistry
Feb 26, 2009
0
0
Existing flu vaccines provide only limited, seasonal protection because they target highly changeable proteins on the virus. Scripps Research scientists have now designed a vaccine that should work broadly against influenza ...
Bio & Medicine
Dec 8, 2023
0
51
Simon Fraser University researchers studying the evolutionary history of flu viruses have found that a new quantitative analysis of how they evolved may help predict future strains. The research draws on a field known as ...
Evolution
Nov 6, 2023
0
35
A successful long-term experiment with live hogs indicates Nebraska scientists may be another step closer to achieving a safe, long-lasting and potentially universal vaccine against swine flu.
Veterinary medicine
Jun 6, 2023
0
46
People who avoid COVID-19 precautions to prevent illness are more likely to purchase firearms—a pattern of behavior most common among moderate and conservative individuals, according to a Rutgers study.
Social Sciences
Apr 10, 2023
29
412
Each year, the flu vaccine has to be redesigned to account for mutations that the virus accumulates, and even then, the vaccine is often not fully protective for everyone.
Cell & Microbiology
Oct 7, 2020
0
419
Influenza viruses mutate rapidly, which is why flu vaccines have to be redesigned every year. A new study from MIT sheds light on just how these viruses evolve so quickly, and offers a potential way to slow them down.
Biochemistry
Sep 26, 2017
0
284
Flu vaccines delivered using microneedles that dissolve in the skin can protect people against infection even better than the standard needle-delivered vaccine, according to new research published in Biomaterials. The authors ...
Biochemistry
Jul 14, 2015
1
68
(Phys.org)—A joint research effort by the Friedrich-Loeffler-Institute and pharmaceutical company CureVac, both based in Germany, has resulted in the creation of a new type of flu vaccine. The vaccine, as the team describes ...
